| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Short Communications |
From the Department of Neurology,*
University of
Cambridge, United Kingdom; Medical Research Council Laboratory of
Molecular Biology,
Hills Road, Cambridge CB2
2QH, United Kingdom; Department of Pathology,
Vrije Universiteit, Amsterdam; and the Departments of
Clinical Genetics§
and
Neurology,¶
Erasmus University Rotterdam,
The Netherlands
Different mutations in the microtubule-associated tau protein gene have recently been identified in several families with hereditary frontotemporal dementia and Parkinsonism (FTDP-17) linked to chromosome 17q21–22. Some families show neuronal and glial deposits containing hyperphosphorylated tau in several brain regions. We have investigated the presence of tau deposits by using a panel of anti-tau antibodies in three brains of a family with the P301L mutation (HFTD1) and in another family with the G272V mutation (HFTD2) of the tau gene. Numerous intracytoplasmic tau deposits in neurons, glial cells, and neurites were found in hippocampal formation, neocortex, and substantia nigra. These deposits in three patients from HFTD1 consisted of slender twisted filaments 15 nm wide with variable periodicity and a few straight filaments. Tau extracted from these filaments appeared as two major bands of 64 and 68 kd and a minor band of 72 kd that, after alkaline phosphatase treatment, proved to consist mainly of 4-repeat tau isoforms and one of the 3-repeat isoforms. In three patients from HFTD2 numerous Pick-like bodies were present. The conclusion is that the type and distribution of tau deposits in HFTD1 and HFTD2, the physical structure of filaments, and tau isoform composition in HFTD1 differ from Alzheimer's disease and an FTDP-17 family with a V337M mutation in the tau gene.
This article has been cited by other articles:
 |
|
 |
|
  H. Aoyagi, M. Hasegawa, and A. Tamaoka Fibrillogenic Nuclei Composed of P301L Mutant Tau Induce Elongation of P301L Tau but Not Wild-type Tau J. Biol. Chem., July 13, 2007; 282(28): 20309 - 20318. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Rosenmann, N. Grigoriadis, D. Karussis, M. Boimel, O. Touloumi, H. Ovadia, and O. Abramsky Tauopathy-like Abnormalities and Neurologic Deficits in Mice Immunized With Neuronal Tau Protein. Arch Neurol, October 1, 2006; 63(10): 1459 - 1467. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Murakami, E. Paitel, T. Kawarabayashi, M. Ikeda, M. A. Chishti, C. Janus, E. Matsubara, A. Sasaki, T. Kawarai, A. L. Phinney, et al. Cortical Neuronal and Glial Pathology in TgTauP301L Transgenic Mice: Neuronal Degeneration, Memory Disturbance, and Phenotypic Variation Am. J. Pathol., October 1, 2006; 169(4): 1365 - 1375. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Schindowski, A. Bretteville, K. Leroy, S. Begard, J.-P. Brion, M. Hamdane, and L. Buee Alzheimer's Disease-Like Tau Neuropathology Leads to Memory Deficits and Loss of Functional Synapses in a Novel Mutated Tau Transgenic Mouse without Any Motor Deficits Am. J. Pathol., August 1, 2006; 169(2): 599 - 616. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Bunker, K. Kamath, L. Wilson, M. A. Jordan, and S. C. Feinstein FTDP-17 Mutations Compromise the Ability of Tau to Regulate Microtubule Dynamics in Cells J. Biol. Chem., April 28, 2006; 281(17): 11856 - 11863. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. F. Bronner, B. C. ter Meulen, A. Azmani, L. A. Severijnen, R. Willemsen, W. Kamphorst, R. Ravid, P. Heutink, and J. C. van Swieten Hereditary Pick's disease with the G272V tau mutation shows predominant three-repeat tau pathology Brain, November 1, 2005; 128(11): 2645 - 2653. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Pickering-Brown, M. Baker, T. Nonaka, K. Ikeda, S. Sharma, J. Mackenzie, S. A. Simpson, J. W. Moore, J. S. Snowden, R. de Silva, et al. Frontotemporal dementia with Pick-type histology associated with Q336R mutation in the tau gene Brain, June 1, 2004; 127(6): 1415 - 1426. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Bunker, L. Wilson, M. A. Jordan, and S. C. Feinstein Modulation of Microtubule Dynamics by Tau in Living Cells: Implications for Development and Neurodegeneration Mol. Biol. Cell, June 1, 2004; 15(6): 2720 - 2728. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Wen, S. Yang, R. Liu, A. M. Brun-Zinkernagel, P. Koulen, and J. W. Simpkins Transient Cerebral Ischemia Induces Aberrant Neuronal Cell Cycle Re-entry and Alzheimer's Disease-like Tauopathy in Female Rats J. Biol. Chem., May 21, 2004; 279(21): 22684 - 22692. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Ferrari, F. Hoerndli, T. Baechi, R. M. Nitsch, and J. Gotz {beta}-Amyloid Induces Paired Helical Filament-like Tau Filaments in Tissue Culture J. Biol. Chem., October 10, 2003; 278(41): 40162 - 40168. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. M. Van Deerlin, L. H. Gill, J. M. Farmer, J. Q. Trojanowski, and V. M-Y. Lee Familial Frontotemporal Dementia: From Gene Discovery to Clinical Molecular Diagnostics Clin. Chem., October 1, 2003; 49(10): 1717 - 1725. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Rosso, E. van Herpen, Y. A. L. Pijnenburg, N. S. M. Schoonenboom, P. Scheltens, P. Heutink, and J. C. van Swieten Total tau and Phosphorylated tau 181 Levels in the Cerebrospinal Fluid of Patients With Frontotemporal Dementia Due to P301L and G272V tau Mutations Arch Neurol, September 1, 2003; 60(9): 1209 - 1213. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Jiang, H. Tang, N. Havlioglu, X. Zhang, S. Stamm, R. Yan, and J. Y. Wu Mutations in Tau Gene Exon 10 Associated with FTDP-17 Alter the Activity of an Exonic Splicing Enhancer to Interact with Tra2{beta} J. Biol. Chem., May 23, 2003; 278(21): 18997 - 19007. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Neugroschl and K. L. Davis Biological Markers in Alzheimer Disease Am J Geriatr Psychiatry, December 1, 2002; 10(6): 660 - 677. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Allen, E. Ingram, M. Takao, M. J. Smith, R. Jakes, K. Virdee, H. Yoshida, M. Holzer, M. Craxton, P. C. Emson, et al. Abundant Tau Filaments and Nonapoptotic Neurodegeneration in Transgenic Mice Expressing Human P301S Tau Protein J. Neurosci., November 1, 2002; 22(21): 9340 - 9351. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Zhukareva, K. Shah, K. Uryu, H. Braak, K. Del Tredici, S. Sundarraj, C. Clark, J. Q. Trojanowski, and V. M.-Y. Lee Biochemical Analysis of {tau} Proteins in Argyrophilic Grain Disease, Alzheimer's Disease, and Pick's Disease : A Comparative Study Am. J. Pathol., October 1, 2002; 161(4): 1135 - 1141. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Janssen, E. K. Warrington, H. R. Morris, P. Lantos, J. Brown, T. Revesz, N. Wood, M. N. Khan, L. Cipolotti, N. C. Fox, et al. Clinical features of frontotemporal dementia due to the intronic tau 10+16 mutation Neurology, April 23, 2002; 58(8): 1161 - 1168. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Rosso, W. Kamphorst, B. de Graaf, R. Willemsen, R. Ravid, M. F. Niermeijer, M. G. Spillantini, P. Heutink, and J. C. van Swieten Familial frontotemporal dementia with ubiquitin-positive inclusions is linked to chromosome 17q21-22 Brain, October 1, 2001; 124(10): 1948 - 1957. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Sergeant, B. Sablonniere, S. Schraen-Maschke, A. Ghestem, C.-A. Maurage, A. Wattez, P. Vermersch, and A. Delacourte Dysregulation of human brain microtubule-associated tau mRNA maturation in myotonic dystrophy type 1 Hum. Mol. Genet., September 1, 2001; 10(19): 2143 - 2155. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Gotz, F. Chen, J. van Dorpe, and R. M. Nitsch Formation of Neurofibrillary Tangles in P301L Tau Transgenic Mice Induced by Abeta 42 Fibrils Science, August 24, 2001; 293(5534): 1491 - 1495. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. K. Wszolek, Y. Tsuboi, R. J. Uitti, L. Reed, M. L. Hutton, D. W. Dickson, P. M. Stanford, G. M. Halliday, W. S. Brooks, J. B.J. Kwok, et al. Progressive supranuclear palsy as a disease phenotype caused by the S305S tau gene mutation Brain, August 1, 2001; 124(8): 1666 - 1670. [Full Text] [PDF]
|
|
|
|
|
|
M. Hutton Missense and splice site mutations in tau associated with FTDP-17: Multiple pathogenic mechanisms Neurology, June 12, 2001; 56(90004): S21 - 25. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. King, N. Ghoshal, J. S. Wall, L. I. Binder, and H. Ksiezak-Reding Structural Analysis of Pick's Disease-Derived and in Vitro-Assembled Tau Filaments Am. J. Pathol., April 1, 2001; 158(4): 1481 - 1490. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Miyasaka, M. Morishima-Kawashima, R. Ravid, P. Heutink, J. C. van Swieten, K. Nagashima, and Y. Ihara Molecular Analysis of Mutant and Wild-Type Tau Deposited in the Brain Affected by the FTDP-17 R406W Mutation Am. J. Pathol., February 1, 2001; 158(2): 373 - 379. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. GHETTI, J. R. MURRELL, P. ZOLO, M. G. SPILLANTINI, and M. GOEDERT Progress in Hereditary Tauopathies: A Mutation in the Tau Gene (G389R) Causes a Pick Disease-like Syndrome Ann. N.Y. Acad. Sci., December 1, 2000; 920(1): 52 - 62. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. HUTTON Molecular Genetics of Chromosome 17 Tauopathies Ann. N.Y. Acad. Sci., December 1, 2000; 920(1): 63 - 73. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. GOEDERT, B. GHETTI, and M. G. SPILLANTINI Tau Gene Mutations in Frontotemporal Dementia and Parkinsonism Linked to Chromosome 17 (FTDP-17): Their Relevance for Understanding the Neurogenerative Process Ann. N.Y. Acad. Sci., December 1, 2000; 920(1): 74 - 83. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Rizzu, M. Joosse, R. Ravid, A. Hoogeveen, W. Kamphorst, J. C. van Swieten, R. Willemsen, and P. Heutink Mutation-dependent aggregation of tau protein and its selective depletion from the soluble fraction in brain of P301L FTDP-17 patients Hum. Mol. Genet., December 1, 2000; 9(20): 3075 - 3082. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. ROSSO, W. KAMPHORST, R. RAVID, and J. C. VAN SWIETEN Coexistent Tau and Amyloid Pathology in Hereditary Frontotemporal Dementia with Tau Mutations Ann. N.Y. Acad. Sci., December 1, 2000; 920(1): 115 - 119. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. von Bergen, P. Friedhoff, J. Biernat, J. Heberle, E.-M. Mandelkow, and E. Mandelkow Assembly of tau protein into Alzheimer paired helical filaments depends on a local sequence motif (306VQIVYK311) forming beta structure PNAS, May 9, 2000; 97(10): 5129 - 5134. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Arima, A. Kowalska, M. Hasegawa, M. Mukoyama, R. Watanabe, M. Kawai, K. Takahashi, T. Iwatsubo, T. Tabira, and N. Sunohara Two brothers with frontotemporal dementia and parkinsonism with an N279K mutation of the tau gene Neurology, May 9, 2000; 54(9): 1787 - 1795. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. M. Stanford, G. M. Halliday, W. S. Brooks, J. B. J. Kwok, C. E. Storey, H. Creasey, J. G. L. Morris, M. J. Fulham, and P. R. Schofield Progressive supranuclear palsy pathology caused by a novel silent mutation in exon 10 of the tau gene: Expansion of the disease phenotype caused by tau gene mutations Brain, May 1, 2000; 123(5): 880 - 893. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Heutink Untangling tau-related dementia Hum. Mol. Genet., April 1, 2000; 9(6): 979 - 986. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. C. Wilhelmsen The tangled biology of tau PNAS, June 22, 1999; 96(13): 7120 - 7121. [Full Text] [PDF]
|
|
|
|
|
|
N. Matsumura, T. Yamazaki, and Y. Ihara Stable Expression in Chinese Hamster Ovary Cells of Mutated Tau Genes Causing Frontotemporal Dementia and Parkinsonism Linked to Chromosome 17 (FTDP-17) Am. J. Pathol., June 1, 1999; 154(6): 1649 - 1656. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. D. Bird, D. Nochlin, P. Poorkaj, M. Cherrier, J. Kaye, H. Payami, E. Peskind, T. H. Lampe, E. Nemens, P. J. Boyer, et al. A clinical pathological comparison of three families with frontotemporal dementia and identical mutations in the tau gene (P301L) Brain, April 1, 1999; 122(4): 741 - 756. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Goedert and M. Hasegawa The Tauopathies : Toward an Experimental Animal Model Am. J. Pathol., January 1, 1999; 154(1): 1 - 6. [Full Text] [PDF]
|
|
|
|
|
|
J. Gotz, F. Chen, R. Barmettler, and R. M. Nitsch Tau Filament Formation in Transgenic Mice Expressing P301L Tau J. Biol. Chem., January 5, 2001; 276(1): 529 - 534. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. D'Souza and G. D. Schellenberg Determinants of 4-Repeat Tau Expression. COORDINATION BETWEEN ENHANCING AND INHIBITORY SPLICING SEQUENCES FOR EXON 10 INCLUSION J. Biol. Chem., June 2, 2000; 275(23): 17700 - 17709. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
